Kevin Herlihy's Colleagues at Glycomine
Kevin Herlihy's Contact Details
HQ
650-401-2016
650-401-2016
Location
Durham,North Carolina,United States
Durham,North Carolina,United States
Company
Glycomine
Glycomine
Kevin Herlihy's Company Details
Glycomine is developing orphan drugs for serious rare disorders of metabolism and protein misfolding for which no other therapeutic options exist. The company's approach is to use replacement therapies – substrates, enzymes, or proteins – and to target those molecules to clinically relevant cellular compartments. Glycomine's lead drug candidate, GLM101, is a novel substrate replacement therapy in development to treat phosphomannomutase 2-congenital disorder of glycosylation (PMM2-CDG), a rare disease representing a critical unmet medical need.
Frequently Asked Questions about Kevin Herlihy
Kevin Herlihy currently works for Glycomine Inc..
Kevin Herlihy's role at Glycomine Inc. is Senior Director of Process Development.
Kevin Herlihy's email address is ***@glycomine.com. To view Kevin Herlihy's full email address, please signup to ConnectPlex.
Kevin Herlihy works in the Biotechnology industry.
Kevin Herlihy's colleagues at Glycomine are Geoffrey Hird, Horacio Plotkin, Teppei Shirakura, Steven Axon, Tristen Moors, Karen Morici, Helen Shapiro and others.
Kevin Herlihy's phone number is 650-401-2016